Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-11 · accession 0001062993-25-005294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-11 | IPSC | Conn Morgan | Chief Finanical Off | A - Grant | $0.00 | +19.5K | 79.6K | +32% | $0 |
| D | 2025-03-12 | 2025-03-11 | IPSC | Conn Morgan | Chief Finanical Off | A - Grant | $0.00 | +19.5K | 19.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-11 | A | A | 19,500 | $0.00 | 79,648 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. |
| 2 | Derivative | Stock Option (right to buy) | 2025-03-11 | A | A | 19,500 | $0.00 | 19,500 | D | $0.6 · — to 2035-03-11 | 19,500 Common Stock | (F2) The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. |